Shrink to Commercialize Revolutionary Material and Fabrication Process Designed to Improve Solar Cell Efficiency

Shrink Technologies, Inc., a California corporation, has agreed to be acquired in a stock-for-stock transaction by AudioStocks, Inc. (OTCBB: AUIO). The companies have executed a binding letter of intent and expect to conclude the transaction by the end of May.

Shrink is dedicated to the commercial adoption of an innovative nanofabrication platform, invented by Dr. Michelle Khine, which provides for the rapid design and low-cost fabrication – on polystyrene and other biodegradable plastics – of micro and nanostructures for devices with a wide range of applications, including next generation solar cell substrates, wave guides for integrated circuits, microfluidic devices, stem cell research tools, biochips and LEDs to name a few. Shrink holds an exclusive license from the largest public university system in California which covers the right to commercialize 10 patent-pending inventions related to its technologies.

Shrink has created the PolyShrink Manufacturing Solution™ which utilizes the unique characteristics of PolyShrink™, a shrinkable thermo-plastic material, which enables complex structures to be designed at the macro-scale, while retaining the original designs on a much smaller scale. PolyShrink™ based applications can be designed and prototyped in a few hours versus conventional methods using silicon or other materials that require costly equipment and labor intensive processes. Shrink creates features on PolyShrink™ that retract isotropically, after the application of heat, to a fraction of the original size. Because the patterned features “shrink,” Shrink devices do not require high-resolution printing which is otherwise necessary to achieve such fine features. This flexible and elegant design and fabrication solution saves costs by eliminating the need for millions of dollars in cleanroom equipment and vastly improves time-to-market for products in Shrink’s focused market segments.

Mark L. Baum, CEO of Shrink, commented, “For nearly two years our team has been working diligently to prepare Shrink for an introduction to the public equity markets. In that time, we executed an option agreement to license our core technologies and agreed to fund a multi-year research and development agreement with the university where our innovations were born. We are also proud to have reached a milestone agreement with the largest public university system in California which provides Shrink with an exclusive license to certain core patent-pending inventions, as well as numerous additional patent-pending inventions, all of which allow our Company to continue to work towards commercializing a plethora of innovative solutions for a number of fast growing multi-billion market segments. From a financial perspective, what is also notable in our exclusive licensing agreement is that the licensor has agreed to accept 100% of the initial licensing fees in equity, based on a $1.01 stock price.”

Shrink was founded in the State of California on January 15, 2008. Shrink represents the first start-up company to come out of the University of California Merced, and brings together leading scientists, business advisors and an executive team that is dedicated to bringing its exclusively licensed technology to the commercial marketplace. Shrink addresses the growing global need for leading edge technology through more efficient design and manufacturing technology by integrating the rapid deployment of affordable products that were never before possible. The modern global economy has seen the rise and accepted the need for greater sustainability. Shrink solutions, including its substrates, devices and research tools are being designed to not only mechanically effective in the solar energy, environmental detection, stem cell and biotechnology markets, they are also being made from biodegradable materials, including corn-based plastics.

PolyShrink™ is based on polystyrene, a ubiquitous plastic material that has been used in countless industrial applications due to its flexible material properties and relative ease of use. By taking advantage of these inherent characteristics, PolyShrink™ allows for the ultra-rapid direct patterning of complex even three-dimensional, stacked polystyrene micro- and nanostructures as well as advanced optoelectronic devices. Because of the unique characteristic of PolyShrink™ to uniformly compress during heating, complex structures can be designed at the macro-scale level, yet upon heating, these designs are retained at the micro- or nano-scale.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Shrink Nanotechnologies. (2019, February 14). Shrink to Commercialize Revolutionary Material and Fabrication Process Designed to Improve Solar Cell Efficiency. AZoNano. Retrieved on April 18, 2024 from https://www.azonano.com/news.aspx?newsID=11531.

  • MLA

    Shrink Nanotechnologies. "Shrink to Commercialize Revolutionary Material and Fabrication Process Designed to Improve Solar Cell Efficiency". AZoNano. 18 April 2024. <https://www.azonano.com/news.aspx?newsID=11531>.

  • Chicago

    Shrink Nanotechnologies. "Shrink to Commercialize Revolutionary Material and Fabrication Process Designed to Improve Solar Cell Efficiency". AZoNano. https://www.azonano.com/news.aspx?newsID=11531. (accessed April 18, 2024).

  • Harvard

    Shrink Nanotechnologies. 2019. Shrink to Commercialize Revolutionary Material and Fabrication Process Designed to Improve Solar Cell Efficiency. AZoNano, viewed 18 April 2024, https://www.azonano.com/news.aspx?newsID=11531.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.